EPISODE · Sep 8, 2022 · 19 MIN
The Race to Prepare for Medicare’s New Drug Pricing Powers
from Tradeoffs
The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.Guests:Alice Valder Curran, JD, Partner, Hogan LovellsSean Dickson, JD, MPH, Director of Health Policy, West Health Policy CenterAmber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human ServicesMark Newsom, Founder and Principal, Health EvaluationsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.Follow us on Twitter. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.Guests:Alice Valder Curran, JD, Partner, Hogan LovellsSean Dickson, JD, MPH, Director of Health Policy, West Health Policy CenterAmber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human ServicesMark Newsom, Founder and Principal, Health EvaluationsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.Follow us on Twitter. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
The Race to Prepare for Medicare’s New Drug Pricing Powers
No transcript for this episode yet
Similar Episodes
Jun 17, 2026 ·26m
Jun 15, 2026 ·43m
Jun 12, 2026 ·22m
Jun 11, 2026 ·25m